102.37USD+0.74%Mkt Cap: 4.27B USDP/E: —Last update: 2026-05-26
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting a…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap4.27B USD
Enterprise Value4.03B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-70.00M USD
Revenue/Share—
Last Price102.37 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-34.88
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.64
EPS (TTM)-2.65
EPS (Forward)-3.00
52W Range
32.0082% of range117.71
52W High117.71 USD
52W Low32.00 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE57.84%
ROA-45.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-71.60M USD
CapEx (TTM)24.00K USD
FCF Margin—
FCF Yield—
Net Debt-141.86M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.00
Current Ratio—
Quick Ratio—
Book Value/Sh-163.8700 USD
Cash/Share3.799 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)131.00 USD
Target Range120.00 USD – 138.00 USD
# Analysts3
Ownership
Shares Out.41.78M
Float24.13M
Insiders2.74%
Institutions80.53%
Short Interest
Short Ratio3.0d
Short % Float9.04%
Short % Out.5.51%
Shares Short2.06M
Short (prev mo.)2.32M
Technical
SMA 5079.93 (+28.1%)
SMA 20068.25 (+50.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)640.26K
Avg Vol (10d)401.78K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—